These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7984635)

  • 1. Release of an alkylating metabolite, dehydromonocrotaline, from the isolated liver perfused with the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Proc West Pharmacol Soc; 1994; 37():107-8. PubMed ID: 7984635
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of the hepatic release of metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1994 Jul; 127(1):58-63. PubMed ID: 8048054
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between the concentration of the pyrrolizidine alkaloid monocrotaline and the pattern of metabolites released from the isolated liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):1-8. PubMed ID: 7839357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between glutathione concentration and metabolism of the pyrrolizidine alkaloid, monocrotaline, in the isolated, perfused liver.
    Yan CC; Huxtable RJ
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):132-9. PubMed ID: 7839360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identity of a biliary metabolite formed from monocrotaline in isolated, perfused rat liver.
    Mattocks AR; Croswell S; Jukes R; Huxtable RJ
    Toxicon; 1991; 29(4-5):409-15. PubMed ID: 1907409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biliary excretion of novel pneumotoxic metabolites of the pyrrolizidine alkaloid, monocrotaline.
    Lafranconi WM; Ohkuma S; Huxtable RJ
    Toxicon; 1985; 23(6):983-92. PubMed ID: 3938082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic glutathione concentrations and the release of pyrrolic metabolites of the pyrrolizidine alkaloid, monocrotaline, from the isolated perfused liver.
    Nigra L; Huxtable RJ
    Toxicon; 1992 Oct; 30(10):1195-202. PubMed ID: 1440625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of a reactive pyrrole in the hepatic metabolism of the pyrrolizidine alkaloid, monocrotaline.
    Glowaz SL; Michnika M; Huxtable RJ
    Toxicol Appl Pharmacol; 1992 Aug; 115(2):168-73. PubMed ID: 1641851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism of [14C]monocrotaline by isolated perfused rat liver.
    Lamé MW; Jones AD; Morin D; Segall HJ
    Drug Metab Dispos; 1991; 19(2):516-24. PubMed ID: 1676664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of monocrotaline on energy metabolism in the rat liver.
    Mingatto FE; Maioli MA; Bracht A; Ishii-Iwamoto EL
    Toxicol Lett; 2008 Nov; 182(1-3):115-20. PubMed ID: 18835426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydromonocrotaline inhibits mitochondrial complex I. A potential mechanism accounting for hepatotoxicity of monocrotaline.
    Mingatto FE; Dorta DJ; dos Santos AB; Carvalho I; da Silva CH; da Silva VB; Uyemura SA; dos Santos AC; Curti C
    Toxicon; 2007 Oct; 50(5):724-30. PubMed ID: 17669457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human liver microsomal reduction of pyrrolizidine alkaloid N-oxides to form the corresponding carcinogenic parent alkaloid.
    Wang YP; Yan J; Fu PP; Chou MW
    Toxicol Lett; 2005 Mar; 155(3):411-20. PubMed ID: 15649625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dehydromonocrotaline induces cyclosporine A-insensitive mitochondrial permeability transition/cytochrome c release.
    dos Santos AB; Dorta DJ; Pestana CR; Maioli MA; Curti C; Mingatto FE
    Toxicon; 2009 Jul; 54(1):16-22. PubMed ID: 19285518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trapping of short-lived electrophilic metabolites of pyrrolizidine alkaloids escaping from perfused rat liver.
    Mattocks AR; Legg RF; Jukes R
    Toxicol Lett; 1990 Nov; 54(1):93-9. PubMed ID: 2244344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the pyrrolizidine alkaloid, monocrotaline, on bile composition of the isolated, perfused rat liver.
    Yan CC; Huxtable RJ
    Life Sci; 1995; 57(6):617-26. PubMed ID: 7623629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic activation of retronecine and retronecine N-oxide - formation of DHP-derived DNA adducts.
    Yan J; Xia Q; Chou MW; Fu PP
    Toxicol Ind Health; 2008 Apr; 24(3):181-8. PubMed ID: 18842697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formation of DHP-derived DNA adducts from metabolic activation of the prototype heliotridine-type pyrrolizidine alkaloid, heliotrine.
    Xia Q; Yan J; Chou MW; Fu PP
    Toxicol Lett; 2008 May; 178(2):77-82. PubMed ID: 18395999
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of taurine on biliary metabolites of glutathione in liver perfused with the pyrrolizidine alkaloid, monocrotaline.
    Yan CC; Huxtable RJ
    Adv Exp Med Biol; 1998; 442():85-9. PubMed ID: 9635018
    [No Abstract]   [Full Text] [Related]  

  • 19. Association of dehydromonocrotaline with rat red blood cells.
    Lamé MW; Jones AD; Morin D; Wilson DW; Segall HJ
    Chem Res Toxicol; 1997 Jun; 10(6):694-701. PubMed ID: 9208177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of the lipophilic nature of a series of penicillin on their biliary excretion in the isolated and perfused liver].
    Cantelli Forti G; Biagi GL; Rossi T
    G Ital Chemioter; 1979; 26(1-2):227-31. PubMed ID: 554814
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.